Femoropopliteal Interventions for Peripheral Artery Disease: A Review of Current Evidence and Future Directions.

Interv Cardiol Clin

Durham Veterans Administration Medical Center, Durham, NC, USA; Department of Medicine, Division of Cardiology, Duke University Health System, 508 Fulton Street, Durham, NC 27705, USA.

Published: April 2025

The femoropopliteal segment is a common anatomic location for peripheral artery disease. The clinical presentation of occlusive disease of the femoropopliteal segment can range from symptomatic or severe claudication if in isolation, or acute or chornic limb threatening ischemia often in the setting of multilevel disease. Patients can be treated with various therapies to improve symptoms and restore perfusion, including medical, exercise, endovascular, and open surgical therapies. The current literature is rapidly evolving on the best management algorithms and strategies based on patient presentation, severity of occlusive disease, and desired therapy goals. This paper summarizes current literature on available medical, endovascular, and surgical therapies for treating peripheral artery occlusive disease of the femoropopliteal segment.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.iccl.2024.11.010DOI Listing

Publication Analysis

Top Keywords

peripheral artery
12
femoropopliteal segment
12
occlusive disease
12
artery disease
8
disease femoropopliteal
8
surgical therapies
8
current literature
8
disease
6
femoropopliteal
4
femoropopliteal interventions
4

Similar Publications

ObjectivesInfection of peripheral interposition grafts is a rare but devastating complication following aneurysm repair. Typically, graft infection necessitates explantation and, if possible, revascularization of the limb. However, treatment complexity varies substantially depending on the location and extent of infection.

View Article and Find Full Text PDF

IntroductionPeripheral artery disease (PAD) poses a growing clinical challenge due to an aging population, despite advances in treatment methods. Various scoring systems have emerged to predict high-risk patients, including the HALP (hemoglobin, albumin, lymphocyte, and platelet) score, known for predicting prognosis in cancers and stroke. This study assesses the HALP score's relation to lesion severity and long-term mortality in PAD patients.

View Article and Find Full Text PDF

Ergot alkaloids present in endophyte-infected tall fescue can cause a series of negative effects in exposed cattle. This study evaluated the effectiveness of molasses-based block supplements (MBSs) in alleviating vasoconstriction, which leads to reduced peripheral blood flow, heat stress, and impaired growth performance in cattle. A total of 100 crossbred steers were assigned to five treatment groups: a negative control with no tall fescue seed; a positive control with ergot-infected tall fescue seeds; and three MBS treatments, including a control block, a block containing menthol, and a block containing capsaicin.

View Article and Find Full Text PDF

Water Hammer Phenomenon in Coronary Arteries: Scientific Basis for Diagnostic and Predictive Modeling with Acoustic Action Mapping.

Diagnostics (Basel)

February 2025

Vietnam Association for Fluid Mechanics and Water Resources Engineering Department, University of Science and Technology, The University of Danang, Danang 550000, Vietnam.

In the study of coronary artery disease, the mechanisms underlying atherosclerosis initiation and progression or regression remain incompletely understood. Our research conceptualized the cardiovascular system as an integrated network of pumps and pipes, advocating for a paradigm shift from static imaging of coronary stenosis to dynamic assessments of coronary flow. Further review of fluid mechanics highlighted the water hammer phenomenon as a compelling analog for processes in coronary arteries.

View Article and Find Full Text PDF

The IL-6 axis in vascular inflammation: effects of IL-6 receptor blockade on vascular lesions from patients with giant-cell arteritis.

Ann Rheum Dis

March 2025

Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic (member of European Reference Network [ERN]-for rare diseases RITA), University of Barcelona, Centre de Recerca biomèdica (CRB)-CELLEX, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Electronic address:

Objectives: Blocking interleukin (IL)-6-receptor with tocilizumab has been a major advance in the treatment of giant-cell arteritis (GCA), supporting a crucial role of IL-6 receptor signalling. However, nearly half of the patients are not able to maintain glucocorticoid- free remission with tocilizumab. The impact of tocilizumab on vascular lesions of GCA is largely unknown since conflicting results have been obtained by imaging.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!